WO2016159582A3 - Composition for innate immunity enhancement and antiviral activity containing schizonepeta tenuifolia extract as active ingredient - Google Patents

Composition for innate immunity enhancement and antiviral activity containing schizonepeta tenuifolia extract as active ingredient Download PDF

Info

Publication number
WO2016159582A3
WO2016159582A3 PCT/KR2016/003041 KR2016003041W WO2016159582A3 WO 2016159582 A3 WO2016159582 A3 WO 2016159582A3 KR 2016003041 W KR2016003041 W KR 2016003041W WO 2016159582 A3 WO2016159582 A3 WO 2016159582A3
Authority
WO
WIPO (PCT)
Prior art keywords
innate immunity
antiviral activity
immunity enhancement
enhancement
composition
Prior art date
Application number
PCT/KR2016/003041
Other languages
French (fr)
Korean (ko)
Other versions
WO2016159582A2 (en
Inventor
마진열
조원경
이종수
Original Assignee
한국 한의학 연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국 한의학 연구원 filed Critical 한국 한의학 연구원
Publication of WO2016159582A2 publication Critical patent/WO2016159582A2/en
Publication of WO2016159582A3 publication Critical patent/WO2016159582A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538—Schizonepeta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Fodder In General (AREA)

Abstract

The present invention relates to a pharmaceutical composition for innate immunity enhancement and antiviral activity containing a Schizonepeta tenuifolia extract as an active ingredient, a health functional food for innate immunity enhancement and antiviral activity containing a Schizonepeta tenuifolia extract as an active ingredient, a feed composition for innate immunity enhancement and antiviral activity containing a Schizonepeta tenuifolia extract as an active ingredient, and a method for innate immunity enhancement and antiviral activity enhancement in an animal, the method comprising administering a Schizonepeta tenuifolia extract to an animal excluding humans, in need of innate immunity enhancement. The Schizonepeta tenuifolia-containing composition for innate immunity enhancement and antiviral activity according to the present invention exhibits antiviral activity and innate immunity enhancement efficacy, and thus can be applied for prevention and treatment of bacterial and viral infectious diseases, and can be widely used for a medicine or a health functional food for immunity enhancement and regulation in immunodeficient or immunosuppressed patients and for a feed for innate immunity enhancement and antiviral activity, for the purpose of anti-disease enhancement of animals. Furthermore, the composition for innate immunity enhancement and antiviral activity according to the present invention scarcely causes toxicity or side effects, and thus can be safely used even in the long-term use for prophylactic purposes.
PCT/KR2016/003041 2015-03-27 2016-03-25 Composition for innate immunity enhancement and antiviral activity containing schizonepeta tenuifolia extract as active ingredient WO2016159582A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0042933 2015-03-27
KR1020150042933A KR101770573B1 (en) 2015-03-27 2015-03-27 Composition for enhancing innate immunity and antivirus comprising Schizonepetae Spica extract as effective component

Publications (2)

Publication Number Publication Date
WO2016159582A2 WO2016159582A2 (en) 2016-10-06
WO2016159582A3 true WO2016159582A3 (en) 2016-12-08

Family

ID=57006105

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/003041 WO2016159582A2 (en) 2015-03-27 2016-03-25 Composition for innate immunity enhancement and antiviral activity containing schizonepeta tenuifolia extract as active ingredient

Country Status (2)

Country Link
KR (1) KR101770573B1 (en)
WO (1) WO2016159582A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102309437B1 (en) 2018-01-19 2021-10-07 건국대학교 산학협력단 Implementation of Surface Repeating Structure Dextran Nanogels binding to Pattern Recognition Retinoic acid-Inducible Gene-I-like Receptors
KR102161020B1 (en) 2018-12-04 2020-10-05 한국식품연구원 Composition comprising a extract of Schizonepeta tenuifolia having Advanced Glycation End product inhibitory activity effects
US11260097B2 (en) 2020-07-06 2022-03-01 COVImmune Pharma LLC Immunomodulatory composition to treat and/or prevent COVID-19 illness
KR102663613B1 (en) * 2022-10-13 2024-05-16 주식회사 케이씨앤씨 Composition for preventing or treating of feline infectious peritonitis comprising Schizonepeta tenuifolia extract as an active ingredient

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102512532A (en) * 2011-12-15 2012-06-27 孙旭初 Medicine composition for preventing and treating diseases of quail
KR101164515B1 (en) * 2009-11-05 2012-07-11 한국 한의학 연구원 Composition for Prevention or Treatment of Disease Originated from Influenza Virus
KR20130058790A (en) * 2011-11-28 2013-06-05 주식회사 진생사이언스 Pharmaceutical composition comprising the extract of schizonepeta tenuifolia var. japonica for preventing and treating osteoporosis or promoting body growth
KR20130062113A (en) * 2011-12-02 2013-06-12 재단법인 한국한방산업진흥원 A topical composition comprising the extract of schizonepta tenuifolia as an active ingredient for preventing and treating inflammatory disease
CN104306660A (en) * 2014-10-10 2015-01-28 天津瑞贝特科技发展有限公司 Traditional Chinese medicine composition for treating viral diseases of poultry and preparation method of traditional Chinese medicine composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101164515B1 (en) * 2009-11-05 2012-07-11 한국 한의학 연구원 Composition for Prevention or Treatment of Disease Originated from Influenza Virus
KR20130058790A (en) * 2011-11-28 2013-06-05 주식회사 진생사이언스 Pharmaceutical composition comprising the extract of schizonepeta tenuifolia var. japonica for preventing and treating osteoporosis or promoting body growth
KR20130062113A (en) * 2011-12-02 2013-06-12 재단법인 한국한방산업진흥원 A topical composition comprising the extract of schizonepta tenuifolia as an active ingredient for preventing and treating inflammatory disease
CN102512532A (en) * 2011-12-15 2012-06-27 孙旭初 Medicine composition for preventing and treating diseases of quail
CN104306660A (en) * 2014-10-10 2015-01-28 天津瑞贝特科技发展有限公司 Traditional Chinese medicine composition for treating viral diseases of poultry and preparation method of traditional Chinese medicine composition

Also Published As

Publication number Publication date
KR101770573B1 (en) 2017-08-24
WO2016159582A2 (en) 2016-10-06
KR20160115376A (en) 2016-10-06

Similar Documents

Publication Publication Date Title
PH12018550150A1 (en) Elimination of hepatitis b virus with antiviral agents
WO2017022962A8 (en) Composition for preventing or treating immune disease, comprising ripk inhibitor as active ingredient
PH12018500044A1 (en) Stuffy nose deblocking composition having antiviral activity
WO2016159582A3 (en) Composition for innate immunity enhancement and antiviral activity containing schizonepeta tenuifolia extract as active ingredient
MX2021013139A (en) Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient.
EP4218823A3 (en) Novel polymeric hgh prodrugs
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
WO2016159583A3 (en) Composition for innate immunity enhancement and antiviral activity containing hovenia dulcis extract as active ingredient
WO2016159584A3 (en) Composition for innate immunity enhancement and antiviral activity containing extract of mori ramulus or mori radicis cortex as active ingredient
WO2015048188A8 (en) Modified fibroblast growth factors for the treatment of ocular disorders
MX2018000092A (en) New bicyclic lipolantipeptide, preparation and use as antimicrobial agent.
NZ599039A (en) Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry
RU2014117294A (en) 4,6-DI (3,12-DIAZA-6,9-DIAZONIADISPIRO [5.2.5.2] HEXADECAN-1-IL) -2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE DIHYDROCHLORIDE HEXAHYDRATE FOR THE TREATMENT OF CHEMISE
MY194024A (en) Use of cistanche tubulosa extract and isoacteoside in protection of muscles
MX2018004796A (en) Preservation of water-soluble vitamins.
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
BR112017016278A2 (en) Prevention and/or the medical treatment agent of immunopathy
ZA201905309B (en) Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals
WO2016159581A3 (en) Composition for innate immunity enhancement and antiviral activity containing aster tataricus extract as active ingredient
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)
MX2018011539A (en) Treatment of skin conditions and diseases associated with microbial biofilms.
GB202017123D0 (en) Non-toxic furocoumarin-rich plant extracts and related compositions for use as antimicrobial substances or medicament and other therapeutic uses.
GB2550750A (en) Anthelmintic compounds
EP3795170C0 (en) Pharmaceutical composition comprising ccn5 as active ingredient for preventing or treating retinal diseases
MX2018013474A (en) Carboxylic acids for early childhood application.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16773363

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16773363

Country of ref document: EP

Kind code of ref document: A2